Target
Suppressor of tumorigenicity 14 protein
Ligand
BDBM50017920
Substrate
n/a
Meas. Tech.
ChEMBL_1364433 (CHEMBL3294545)
Ki
10.0±n/a nM
Citation
 Goswami, RMukherjee, SGhadiyaram, CWohlfahrt, GSistla, RKNagaraj, JSatyam, LKSubbarao, KPalakurthy, RKGopinath, SKrishnamurthy, NRIkonen, TMoilanen, ASubramanya, HSKallio, PRamachandra, M Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy. Bioorg Med Chem 22:3187-203 (2014) [PubMed]  Article 
Target
Name:
Suppressor of tumorigenicity 14 protein
Synonyms:
Epithin | Hepatocyte growth factor activator/Serine protease hepsin/Suppressor of tumorigenicity 14 protein | MT-SP1 | Membrane-type serine protease 1 | PRSS14 | Prostamin | SNC19 | ST14 | ST14_HUMAN | Serine protease TADG-15 | Suppressor of tumorigenicity 14 protein | Suppressor of tumorigenicity protein 14 | TADG15
Type:
Single-pass type II membrane protein
Mol. Mass.:
94769.23
Organism:
Homo sapiens (Human)
Description:
Q9Y5Y6
Residue:
855
Sequence:
MGSDRARKGGGGPKDFGAGLKYNSRHEKVNGLEEGVEFLPVNNVKKVEKHGPGRWVVLAAVLIGLLLVLLGIGFLVWHLQYRDVRVQKVFNGYMRITNENFVDAYENSNSTEFVSLASKVKDALKLLYSGVPFLGPYHKESAVTAFSEGSVIAYYWSEFSIPQHLVEEAERVMAEERVVMLPPRARSLKSFVVTSVVAFPTDSKTVQRTQDNSCSFGLHARGVELMRFTTPGFPDSPYPAHARCQWALRGDADSVLSLTFRSFDLASCDERGSDLVTVYNTLSPMEPHALVQLCGTYPPSYNLTFHSSQNVLLITLITNTERRHPGFEATFFQLPRMSSCGGRLRKAQGTFNSPYYPGHYPPNIDCTWNIEVPNNQHVKVRFKFFYLLEPGVPAGTCPKDYVEINGEKYCGERSQFVVTSNSNKITVRFHSDQSYTDTGFLAEYLSYDSSDPCPGQFTCRTGRCIRKELRCDGWADCTDHSDELNCSCDAGHQFTCKNKFCKPLFWVCDSVNDCGDNSDEQGCSCPAQTFRCSNGKCLSKSQQCNGKDDCGDGSDEASCPKVNVVTCTKHTYRCLNGLCLSKGNPECDGKEDCSDGSDEKDCDCGLRSFTRQARVVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV
  
Inhibitor
Name:
BDBM50017920
Synonyms:
CHEMBL3289042
Type:
Small organic molecule
Emp. Form.:
C28H32N6O3
Mol. Mass.:
500.5921
SMILES:
N[C@H]1CC[C@@H](CC1)NC(=O)c1cc(OCc2ccc(cc2)C(N)=N)cc(Oc2ccc(cc2)C(N)=N)c1 |r,wU:4.7,wD:1.0,(3.93,1.19,;4.7,-.15,;3.93,-1.48,;4.7,-2.81,;6.24,-2.81,;7.01,-1.48,;6.24,-.15,;7.01,-4.15,;8.55,-4.15,;9.32,-2.81,;9.32,-5.48,;10.86,-5.48,;11.63,-6.81,;13.17,-6.81,;13.94,-5.48,;15.48,-5.48,;16.25,-4.15,;17.79,-4.15,;18.56,-5.48,;17.79,-6.81,;16.25,-6.81,;20.1,-5.48,;20.87,-6.81,;20.87,-4.15,;10.86,-8.15,;9.32,-8.15,;8.55,-9.48,;7.01,-9.48,;6.24,-10.82,;4.7,-10.82,;3.93,-9.48,;4.7,-8.15,;6.24,-8.15,;2.39,-9.48,;1.62,-8.15,;1.62,-10.82,;8.55,-6.81,)|
Structure:
Search PDB for entries with ligand similarity: